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Abstract
Inorganic nanostructures have been used extensively to package nucleic acids into forms useful for
therapeutic applications. Here we report that the two products of transcription, RNA and inorganic
pyrophosphate, can self-assemble to form composite microsponge structures composed of
nanocrystalline magnesium pyrophosphate sheets (Mg2P2O7·3.5H2O) with RNA adsorbed to their
surfaces. The microsponge particles contain high loadings of RNA (15–21 wt.%) that are
protected from degradation and can be obtained through a rolling circle mechanism as large
concatemers capable of mediating RNAi. The morphology of the RNAi microsponges is
influenced by the time-course of the transcription reaction and interactions between RNA and the
inorganic phase. Previous work demonstrated that polycations can be used to condense RNAi
microsponges into nanoparticles capable of efficient transfection with low toxicity. Our new
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findings suggest that the formation of these nanoparticles is mediated by the gradual dissolution of
magnesium pyrophosphate that occurs in the presence of polycations. The simple one-pot
approach for assembling RNAi microsponges along with their unique properties could make them
useful for RNA-based therapeutics.
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1. Introduction
Rolling circle replication (RCR) is a strategy employed by some of the simplest biological
entities (e.g., viroids, phages, and plasmids) to efficiently copy their genomes.[1-3] Through
the action of a polymerase enzyme continuously traversing a circular template, RCR allows
for large linear repeats (concatemers) complementary to the template sequence to be rapidly
generated. In addition to its important role in biology, RCR can be carried out in cell-free
systems from synthetic circular templates to produce large quantities of DNA or RNA
through processes referred to as rolling circle amplification (RCA) and rolling circle
transcription (RCT), respectively.[4-6] The rapid and specific isothermal amplification
enabled by this technique has led to its use for numerous applications, including the highly
sensitive detection of DNA, RNA, and proteins.[7-11].
In addition to its utility for signal amplification and detection, RCR also provides a simple
and unique approach for synthesizing large, periodic nucleic acids with interesting
properties. By designing appropriate templates, the concatemeric DNA or RNA obtained by
RCR can be made to contain high densities of functional units, such as ribozymes, shRNA,
and aptamers.[12-15] Recently, researchers have also begun investigating the self-assembly
of nucleic acids produced by RCR into diverse nanostructures.[16-21] This has been
achieved through different approaches that often employ the rolling circle product as a
structural scaffold for other materials, such as complementary nucleic acids, peptides, and
inorganic nanoparticles. These exciting applications of RCR could lead to new routes for
designing programmable materials with both inherent biological activity and unique
structural properties.
Small interfering RNAs (siRNAs) show great potential for the treatment of many diseases
due to their ability to inhibit the expression of specific genetic targets.[22-24] The effective
use of siRNA as a therapeutic agent, however, requires its efficient packaging in order to
facilitate cellular uptake and prevent degradation.[25-28] Several nucleic acid self-assembly
approaches, including the use of structural DNA scaffolds and the phi29 pRNA motif, have
been employed to generate siRNA-containing nanostructures for in vivo delivery.[29-34]
Recently, our group reported that RNA synthesized from a circular DNA template resulted
in the self-assembly of spherulitic microsponge particles that were shown to contain RNA
and were capable of inhibiting gene expression in vivo (RNAi microsponges).[35] Herein,
we report new findings on the structure, composition, and mechanism of formation for these
particles. Our new results demonstrate that these microsponges are composite materials
Shopsowitz et al. Page 2
Small. Author manuscript; available in PMC 2014 May 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
consisting of RNA and crystalline magnesium pyrophosphate sheets. Self-assembly of the
microsponges is driven by the formation of pyrophosphate anions (PPi) during transcription,
with structural evolution being related to the kinetics of the RCT reaction combined with
interactions between RNA and the inorganic phase. These results shed new light on the
formation of RNAi microsponges during RCT and highlight the potential for organic and
inorganic molecules generated from a single reaction to coassemble into nanostructures.
2. Results
2.1 Structural Characterization of Microsponges Prepared Using Different DNA Templates
It was previously reported that transcription from a circular DNA template containing a 21
bp double-stranded region in combination with a T7 promoter sequence (referred to as
DNA-T1 in the current study) could lead to the formation of particles with microsponge
morphology.[35] These particles were found to be nanocrystalline and originally proposed
to be composed mostly of RNA. In order to better understand the formation of these
microsponge particles, we sought to further investigate the nature of the assembled
microstructures, and the influence of the DNA template design on the resulting structures. A
dumbbell-shaped DNA molecule with a 21 bp double-stranded region joined by two small
single-stranded loops was prepared (DNA-T2), and employed as an alternative template for
transcription with T7 RNA polymerase (Scheme 1, otherwise identical versions designed to
target GFP or luciferase were used interchangeably throughout the study unless specifically
noted). Compared to DNA-T1 (85 bases), DNA-T2 is shorter (57 bases) as it does not
contain a promoter sequence (for the specific sequences used in this study, see the
Supporting Information). Seyhan et al. previously reported that rolling circle transcription
carried out from dumbbell-shaped DNA templates analogous to DNA-T2 yielded large RNA
molecules capable of silencing gene expression; however, they did not report the formation
of particles from this reaction.[12]
When in vitro transcription was carried out from DNA-T2, a white precipitate formed that
was isolated by centrifugation after 24 h. This material was examined by scanning electron
microscopy (SEM) and transmission electron microscopy (TEM), which revealed ~1-2 μm
particles (Figure 1) with the microsponge morphology previously observed for particles
isolated after transcription from DNA-T1(throughout the rest of the paper, particles
generated from DNA-T1 and DNA-T2 will be referred to as MS-1 and MS-2, respectively).
[35]
Powder X-ray diffraction (PXRD) was carried out to compare the crystallinity of MS-1 and
MS-2 and revealed nearly identical diffraction patterns for the two samples (Figure 2a).
After further analysis of the diffraction patterns, comparisons to inorganic structural
databases ultimately suggested a match with a magnesium pyrophosphate phase, namely
Mg2P2O7•3.5H2O.[36] The pyrophosphate anion (PPi) is a product of transcription, with
one PPi molecule generated for every nucleotide triphosphate that is incorporated into the
growing RNA chain. As a result, PPi produced during enzymatic nucleic acid synthesis can
react with Mg2+ in the reaction buffer to form insoluble magnesium pyrophosphate
(Mg2PPi).[37] To test this, we prepared a sample of magnesium pyrophosphate by reacting
sodium pyrophosphate with an aqueous solution of magnesium chloride using similar
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concentrations to those found during RCT; this resulted in the formation of a white
precipitate that gave the same X-ray diffraction pattern as MS-1 and MS-2 (Figure 2a). To
determine whether the Mg2P2O7•3.5H2O phase is an integral component in the RNAi
microsponges, we added pyrophosphatase enzyme to the transcription reaction and found
that this prevented the formation of the particles altogether. In addition, we found that the
addition of EDTA to the microsponges, which binds strongly to Mg2+, rapidly triggers their
dissolution. Taken together with the previous work from our group, these results
demonstrate that RNA microsponges produced during RCT are inorganic/RNA composite
materials. Although the formation of magnesium pyrophosphate during enzymatic nucleic
acid synthesis is known, the co-assembly of this material with RNA into nanostructured
particles has not been previously investigated.
2.2 Elemental Analysis of Microsponge Composite Structures
To better understand the structure of the microsponge particles, we used energy dispersive
X-ray spectroscopy (EDS) to analyze their elemental composition. Point analysis of the
microsponges using EDS reveals the presence of carbon, nitrogen, oxygen, magnesium, and
phosphorus, which are all consistent with a mixture of RNA and Mg2P2O7(Figure 2b).
Elemental quantification was carried out using both wavelength dispersive X-ray
spectroscopy (WDS) and X-ray photoelectron spectroscopy (XPS), which yield
compositional information related to the bulk (several microns penetration) and surface
(several nanometers penetration) of a material, respectively (Figure 2c-d). Using WDS, we
found atomic percentages of 4.8% C, 64.5% O, 14.8% Mg, and 15.9% P (nitrogen levels
were too low to be accurately quantified). The values for O, Mg, and P are slightly lower
than those predicted for Mg2P2O7•3.5H2O (72.4% O, 13.8% Mg, 13.8% P), which is
consistent with the added presence of RNA. We note that nearly identical results were
obtained for MS-1 and MS-2 samples. When XPS was performed on the same sample, we
measured relative atomic percentages of 5.7% N, 24.5% C, 51.1% O, 8.8% Mg, and 9.8% P.
The large difference between these values and those obtained by WDS demonstrates that the
surface composition of the microsponges is considerably different from their bulk
composition. Specifically, the increased presence of carbon and nitrogen, along with the
decreased relative amounts of oxygen, magnesium, and phosphorus, suggests that the RNA
is enriched at the surface. We proceeded to use scanning transmission electron microscopy
(STEM)-based EDS mapping to further study the localization of magnesium pyrophosphate
and RNA within the particles. The elemental maps for phosphorus and magnesium (Figure
3) show that these elements are concentrated in the sheets that make up the microsponge
particles, demonstrating that the sheet nanostructures likely correspond to the crystalline
magnesium pyrophosphate phase detected by PXRD. The maps for carbon show a fairly
uniform distribution throughout the particles, suggesting an even loading of RNA.
Combined with the XPS data, this leads us to propose that RNA is localized at the surfaces
of the nanocrystalline Mg2P2O7•3.5H2O sheets that make up the microsponge particles.
2.3 Visualization of RNA within Microsponge Particles and Quantification of RNA Loading
We further examined the localization of RNA within the MS-2 particles by carrying out the
transcription reaction in the presence of fluorescent Cy5-labeled UTP, which resulted in a
blue precipitate that retained its color even after multiple wash steps. Confocal fluorescence
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imaging of this sample shows fluorescent particles with dimensions that match those
observed by SEM (Figure 4a-b). These images demonstrate that RNA is distributed
throughout the particles, in accord with the uniform distribution of carbon observed by EDS
mapping. We were also interested in observing what happens to the RNA upon the addition
of EDTA, which as mentioned earlier, causes rapid dissolution of the microsponge particles.
After the addition of 5 mM EDTA to Cy5-labeled MS-2, the particles began to rapidly
change shape, forming spheroid structures, and after ~5 s appeared hollow, suggestive of the
formation of RNA capsule structures (Figure 4c). The hollow structures are transient: 10 s
following the addition of EDTA the particles had all but disappeared with mainly diffuse
fluorescence indicative of free RNA observed (Figure 4d). These results therefore
demonstrate that EDTA is capable of rapidly triggering the release of RNA from the
microsponge particles.
Thermogravimetric analysis (TGA) was used to determine the loading of RNA within the
microsponge particles relative to the inorganic phase. When TGA was performed on the
MS-2 particles, we found that ~50 wt. % remained after heating to 600 °C under air (see the
Supporting Information, Figure S1). By comparison, 63 wt. % remained after subjecting a
control Mg2P2O7•3.5H2O sample (prepared by adding sodium pyrophosphate to the
transcription reaction buffer) to the same thermal treatment; from these measurements, we
calculate an RNA loading of ~21 wt. %. As an alternative method for determining the
weight fraction of RNA in the particles, we measured the total particle mass after drying a
given volume of suspension and compared this value to the RNA concentration measured
with a fluorescence-based assay (ribogreen). This analysis gave a loading of 15.4±2.5 wt. %
RNA, which is comparable to the value obtained by TGA. The RNA quantification
measurements were independently carried out on four separate samples (MS-1 and MS-2
synthesized with different [MgCl2] in the buffer), and all yielded values between 12-15 wt.
%.
2.4 Time Course of RNA Synthesis and Microsponge Formation
A time-dependent synthesis study was conducted to elucidate the mechanism of particle
formation of MS-2 with respect to the time course of the transcription reaction. At each time
point of the experiment, particles were isolated and analyzed by SEM and gel
electrophoresis (Figure 5). In addition, the supernatant was analyzed by electrophoresis and
total RNA (supernatant + MS fraction) was quantified using a ribogreen assay to assess the
overall reaction progress (Figure 5b). The concentration of RNA produced during the
reaction increased continually up until 24 h. The amount of PPi generated during
transcription is equivalent to the amount of RNA produced; therefore the concentration of
PPi must increase at the same rate as RNA over the course of the reaction. Looking at the
supernatant by gel electrophoresis,we see that large transcripts (>1000 bases) are present by
two hours (Figure S2). Further, as the RNA concentration increases at later time points
(9.5-24 h), the size distribution becomes broader with the upper tail approaching 9000 bases.
As a control, when transcription was carried out from the unligated template, we detected a
comparatively small quantity of short transcripts (mostly less than 150 bases, see Figure
S2b). The observed size distribution of RNA and the dependence on ligation are consistent
with concatemeric RNA produced through a rolling circle mechanism.[4, 12, 38]
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In comparison to DNA-T2, we found that DNA-T1 yielded substantially shorter transcripts
(Figure S3). Although ligation had a significant impact on the yield of RNA produced from
DNA-T1, it did not result in transcripts much longer than the size of the template itself. This
indicates that ligation is necessary for efficient initiation from this template (the ligation site
is in the middle of the T7 promoter sequence). However, processive RCT does not appear to
occur from DNA-T1 to the extent that it does from DNA-T2, which could be due to
differences in template length and secondary structure, as well as the added presence of the
T7 promoter sequence. Given that microsponge particles with the same morphology as those
produced from DNA-T2 are obtained from DNA-T1, it appears that the size of the RNA
transcripts does not play a major role in defining particle morphology.
To understand the mechanism of particle formation, the solid produced during RCT was
isolated at different time points and examined by SEM and DLS (Figure 5b-c and Figure
S4). Particles first began to form in the RCT reaction between 2-4 h:at 2 h, we measured a Z
avg. diameter of 346 nm by DLS, but were unable to isolate any solid by centrifugation.
After 4 h, the Z avg. diameter had shrunk to 205 nm and we were able to isolate small
interconnected sheets by centrifugation that had not yet developed into discrete particles
(Figure 5c). After 6 h, the Z avg. diameter had again decreased slightly to 123 nm and the
solid obtained by centrifugation showed regions of well-defined particles of ~250 nm that
resemble miniature versions of the microsponges (Figure 5d). The PPi concentration at this
time point was inferred to be ~0.5 mM (based on RNA concentration), which was
previously found to be near the minimum detectable concentration for magnesium
pyrophosphate-related turbidity during a DNA amplification reaction.[37] By 9.5 h, the
particles had grown significantly larger (Z avg. diameter = 3265 nm) and possessed a well-
defined microsponge morphology (Figure S4). Finally, as the RNA (and hence PPi)
concentration roughly tripled between 9.5-24 h, the size and morphology of the particles did
not seem to change substantially. Using gel electrophoresis, we detected RNA in each of the
samples isolated during particle formation (Figure 5a); RNA is therefore incorporated into
the microsponges throughout the process of their formation. The size distribution of RNA in
the microsponges is similar to what is observed in the supernatant; however, at later time
points it is less broad and shifted to smaller sizes compared to the supernatant RNA. Overall,
we found that ~10-20% of the total RNA produced during RCT was integrated into the
microsponges isolated after 24 h.
2.5 Influence of Pyrophosphate Concentration and the Presence of RNA on Magnesium
Pyrophosphate Formation
The preceding results temporally resolved the formation of RNAi microsponges as a
progression of nucleation of small sheets that grow into larger spheroidal particles as RNA
and PPi are generated during RCT. In order to determine the roles of RNA and PPi
concentration in governing the microsponge morphology, we added varying concentrations
of PPi to MgCl2 solutions in the absence of RNA and isolated the precipitate. When 0.5 mM
PPi (roughly equivalent to the 6 h RCT time point) was added to either the transcription
reaction buffer or a simple aqueous solution of MgCl2 (16 mM), we observed the formation
of ~1 μm spherulitic particles within several hours (Mg2PPi-0.5, Figure 6a-b). These
particles consist of slightly larger, more uniform sheets, and generally appear more like
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traditional spherulites compared to the sponge morphology that forms during RCT. At lower
PPi concentrations, precipitate typically did not form, while at higher concentrations of PPi,
we observed different morphologies. When 2 mM PPi was added, aggregates of particles
with smaller sheets were obtained that more closely resemble the microsponge precursors
seen in Figure 5d; at higher concentrations, the spherulitic morphology was lost altogether
(see Figure S5). The addition of RNA (150 μg/mL isolated from the supernatant of a 24 h
RCT reaction using DNA-T2) prior to the addition of 0.5 mM PPi, drastically changed the
particle morphology compared to the particles formed in the absence of RNA. When RNA
was added, after 4 h we isolated a combination of disordered sheets (akin to those isolated at
early time points of RCT) and large particles that closely resemble the microsponges
obtained during RCT. This result demonstrates that RNA influences the nucleation and
growth of magnesium pyrophosphate, suggesting interactions between RNA and the
crystalline sheets that may explain how RNA is so readily incorporated into the microsponge
particles during RCT.
2.6 RNase Digestion and Transfection of RNA Incorporated in Microsponges
To further assess the localization of RNA within the microsponge particles, we conducted an
RNase protection assay. When MS-2 particles were first broken down with EDTA, we found
that the released RNA was completely degraded within 6 h by RNase If. On the other hand,
some short RNA fragments remained after a 24 h RNase If treatment of the intact MS-2
particles using the same concentration of enzyme (Figure 7a). By observing additional time
points, we found that the large RNA molecules contained within MS-2 were fully converted
to small fragments within 30 min; however, the small fragments were subsequently
degraded more slowly, with 14% remaining after one day. To explain the rapid conversion
of RNA within the microsponges to shorter fragments, we conclude that all of the RNA
molecules must be accessible; this result is consistent with the hypothesis that the RNA is
adsorbed to the surface of the magnesium pyrophosphate sheets that make up the porous
microsponge structure. Localization on the surface of the sheets is also consistent with our
observation that the morphology of the microsponge particles remained unchanged even
after a 48 h RNase treatment (Figure S6). The predicted structure of the RNA generated
from DNA-T2 (21 bp double-stranded regions connected by single stranded segments)
appears to lead to the rapid generation of dsRNA by RNase If, which is selective towards
single-stranded RNA. The double-stranded fragments are then broken down more slowly on
the surface of the microsponge as compared to when free in solution.
Since the double-stranded region of the RNA generated by RCT is the active component for
RNAi, we next tested whether the RNA that remained in the microsponges after treatment
with RNase If was still active for gene silencing (Figure 7c). MS-2 particles containing a
dsRNA sequence targeting GFP were treated with RNase If either before or after their
dissolution with EDTA. As a positive control, we used the same microsponges without
RNase treatment, and, as a negative control, we used microsponges containing a scrambled
dsRNA sequence without RNase treatment. The RNase-treated samples were incubated for 1
h at 37 °C prior to heat-inactivation of the RNase enzyme. All of the samples were dissolved
with EDTA prior to lipofectamine transfection into a GFP over-expressing SKOV3 cell line.
Four days following transfection, the RNase-digested microsponge sample had caused a
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40% decrease in GFP fluorescence relative to the scrambled control, while knockdowns of
30% and 4% were observed for the untreated MS-2 sample and the MS-2 sample that was
dissolved with EDTA prior to RNase treatment, respectively. These results further suggest
that the small fragments produced after the RNase If treatment correspond to the active 21
bp double-stranded portion of the RCT transcripts, and that the microsponges protect this
active region of the RNA from degradation. The improved silencing caused by the RNase-
treated microsponge sample, relative to the positive control, could be attributed to the
lipofectamine being optimized for the transfection of siRNA. Additionally, the partially
digested RNA molecules may not require further intracellular processing by Dicer, which is
believed to be necessary for concatemeric siRNA.[12]
2.7 Interaction of RNA Microsponges and Magnesium Pyrophosphate with Polyethylene
Imine
In our previous work, we found that the addition of linear polyethylene imine (LPEI) to
RNA microsponges resulted in the formation of ~200 nm condensed particles. In order to
test what happens to the inorganic Mg2PPi phase in the presence of LPEI, we added varying
concentrations of LPEI to aqueous suspensions of the Mg2PPi particles formed without
RNA. From DLS, we observed a gradual decrease in the size of the particles that depended
on the amount of LPEI added. For example, when a 5 mg/mL PEI solution was used (the
same concentration previously employed to condense the RNA microsponges),[35] the size
of the Mg2PPi particles decreased from > 1μm to ~200 nm over the course of 18 h. The
remaining solid was isolated by centrifugation and analyzed by SEM and EDS, which
reveals the destruction of the original spherulitic particles into disordered magnesium
pyrophosphate aggregates (Figure S7). These results demonstrate that the conditions
previously used to condense RNA microsponges are also capable of breaking down pure
magnesium pyrophosphate particles.
3. Discussion
Our new findings indicate that RNAi microsponges are self-assembled composite structures
that form through the simultaneous generation of nanocrystalline sheets of
Mg2P2O7•3.5H2O and RNA during transcription. A variety of characterization techniques
suggest that large quantities of RNA are adsorbed onto the surface of the nanocrystalline
sheets: based on TGA and fluorescence-based RNA assays, the weight fraction of RNA in
the microsponges ranges from ~15 to 21%, which compares favorably to other inorganic
particle systems that have been used for siRNA delivery.[39] The growth of the
microsponge particles proceeds through the initial formation of disordered nanosheet
networks at low concentrations of PPi and RNA that gradually form larger spheroidal
microsponges as RNA and PPi are produced during transcription. We found that RNA
appears to be incorporated into the structures early on in the growth process and influences
the resulting morphology. Taken together, these observations lead us to speculate that RNA
provides nucleation sights for the growth of the magnesium pyrophosphate phase. While it
remains unknown what the precise interactions are between the RNA and the
Mg2P2O7•3.5H2O crystal faces, it seems plausible that they are facilitated by the chemical
similarity between pyrophosphate and the RNA sugar-phosphate backbone.
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RNase digestion experiments reveal that the concatemeric RNA present within the
microsponges is highly accessible as evidenced by its rapid conversion to short fragments;
this accessibility is likely related to the highly porous structure of the particles. On the other
hand, localization within the RNA microsponges protects the fragments against further
degradation compared to free RNA. The small fragments produced after RNase If treatment
of the microsponges are still highly active for gene knockdown, which suggests that they
correspond to the double-stranded siRNA region encoded by the DNA template that was
employed. The protection of these regions may be in part due to the nature of the
interactions between the RNA and the Mg2P2O7•3.5H2O nanocrystals; additional studies are
expected to further elucidate the nature of the RNA arrangement on the surface and how this
relates to its protection from degradation.
In our previous work we found that when polycations, such as LPEI, were added to the
RNAi microsponges they would ‘condense’ into smaller nanoparticles approximately 200
nm in size. The resulting nanoparticles exhibited high transfection rates at low
concentrations of nanoparticle and it was postulated that the resulting nanoparticles
contained a large number of siRNA copies compared to typical polyplexes. With our added
understanding of the microsponge structure, one possibility is that when the microsponges
are exposed to polycation solutions, the magnesium pyrophosphate scaffold is deconstructed
through competitive complexation of ions, and the negatively charged micron-scale particle
is condensed into a nanoparticle that contains the RNA previously sequestered on the
nanostructured microsponge surfaces. We have observed that the addition of LPEI leads to a
gradual dissolution of the magnesium pyrophosphate particles formed directly by combining
sodium pyrophosphate and magnesium chloride. We hypothesize that nanoparticles
produced through the simultaneous RNA condensation and crystallite deconstruction of the
inorganic component of the microsponges may form via a different pathway than traditional
polyplexes, yielding potent nanoscale transfection agents with low polycation-based
toxicity. In addition, the size and structure of the RNA produced through RCT might also
influence the properties of the resulting nanoparticles; future work will aim to better
understand how these different factors contribute towards the formation and biological
activity of these materials.
Findings from this work suggest that the yield and structure of microsponge particles formed
during RCT can be controlled through the manipulation of assembly conditions. Currently,
the amount of RNA produced during the rapid RCT process greatly exceeds the loading
capacity of the microsponges that are simultaneously produced; in the supernatant, we find
high concentrations of RNA. The results presented herein, however, suggest that the yield of
microsponge particles can be improved by simply adding an additional source of PPi at the
appropriate concentration. We are currently investigating this avenue to increase the number
of available sponges for co-assembly and loading of RNA, which may provide a route to
much greater amounts of self-assembled RNAi microsponge structures for delivery. Future
work will also entail manipulating the size of microsponges by changing the reaction
conditions to control the number of initiating events that cause sponge nucleation.
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4. Conclusions
We have presented a detailed investigation regarding the mechanism of formation and
composition of self-assembled microsponges that form during RCT. Our results reveal that
the microsponges are composite materials produced through interactions between RNA and
magnesium pyrophosphate generated during transcription. These materials together form
complex sheet networks that further assemble into nanostructured microparticles. We found
that the RNAi microsponges consist of between 15 to 21% RNA by weight, with the
remainder consisting of a nanocrystalline magnesium pyrophosphate phase identified as
Mg2P2O7·3.5H2O. These inorganic sheets provide a high surface area for the presentation of
concatemeric RNA molecules capable of silencing gene expression. The RNA molecules
localized in the microsponge structures are protected from degradation, can be rapidly
released in response to a specific stimulus (EDTA), and are accessible for further
complexation with polycations. It is proposed that the microsponges may act to concentrate
RNA in a form that can ultimately be complexed with polycations to obtain nanoparticles
with high relative siRNA content for delivery applications. Furthermore, this system sheds
light on how interactions between inorganic and organic products of a single reaction can
lead to the assembly of composite nanostructures.
5. Experimental
General
All reagents were purchased from commercial sources and used as received. The plasticware
and water used for all of the experiments were certified RNase and DNase free. T4 DNA
ligase, T7 RNA polymerase, NTP solutions, RNase If, and the corresponding buffers were
purchased from New England Biolabs (NEB). PAGE-purified, 5′-phosphorylated DNA
templates were purchased from Integrated DNA Technologies. Dynamic light scattering and
zeta-potential measurements were carried out using a Malvern Nano-ZS90 zetasizer.
Samples for powder X-ray diffraction (PXRD) were prepared by dropcasting onto small
pieces of copper tape. PXRD measurements were collected using a Rigaku SmartLab
equipped with a 9 kW rotating anode copper source. Data was collected from 5 to 40° 2θ in
a parallel beam configuration with ω fixed at 1° to facilitate measurements from limited
sample quantities. Gel electrophoresis was run on 1.5-2% agarose gels containing GelRed™
in TBE buffer. Samples were prepared using a formamide-containing RNA loading dye
(NEB) according to the manufacturer’s protocol. Gels were run at 3 V/cm and visualized
using a UV transilluminator. SKOV3 human ovarian carcinoma cells were obtained from
ATCC and were cultured according to the provided guidelines. A lentivirus containing a
GFP vector was purchased from Cell Biolabs Inc., and was used to make stable GFP-
expressing SKOV3 cells according to the vendor’s instruction. Lipofectamine was
purchased from Invitrogen.
Ligation of DNA Templates
Ligation of DNA-T1 was carried out using a slight modification of a previously published
procedure. Briefly, the 5′-phosphorylated ssDNA template (0.5 μM) and an ssDNA splint
(1.5 μM) corresponding to the T7 promoter region were combined at a 1:3 molar ratio in the
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ligation reaction buffer (66 mM Tris-HCl, 10 mM MgCl2, 1 mM DTT, 1 mM ATP, 7.5%
PEG 6000, pH 7.6). The two DNA fragments were annealed by heating to 95 °C for 2 min
prior to allowing the solution to cool to 20 °C over the course of ~2 h. Ligation was carried
out by adding T4 DNA ligase (1000 U/100 μL reaction) followed by incubation at 20 °C for
2 h. For DNA-T2, a similar procedure was used except that the splint DNA was omitted and
a higher concentration of the ssDNA (2.2 μM) was used.
Synthesis of RNAi Microsponges
For a typical reaction, 120 μL of the unpurified reaction mixture containing ligated DNA-T1
or DNA-T2, 29 μL of water, 20 μL of 10× T7 RNA polymerase reaction buffer (NEB), 5 μL
of 80 mM NTP solution, and 6 μL of 200 mM MgCl2 were combined and mixed thoroughly
prior to the addition of 20 μL of T7 RNA polymerase (50 U/μL). The reaction was incubated
at 37 °C for 24 h (or shorter for time-course experiments) at which point the reaction
mixture was briefly sonicated and the white solid that had formed was isolated by
centrifugation at 1200 × g for 10 min. The resulting pellet was washed three times with 200
μL of water and resuspended in the same volume of water to give MS-1 or MS-2. For the
synthesis of Cy5-labelled RNAi MS, the exact same procedure was followed excepted that
Cy5-UTP (Enzo Life Sciences) was added to a final concentration of 0.2 mM.
Synthesis of Magnesium Pyrophosphate Control Samples
Magnesium pyrophosphate control samples were synthesized by adding varying amounts of
a freshly prepared 50 mM solution of Na4P2O7•10H2O (Sigma) to 1× T7 RNA polymerase
buffer solution containing 16 mM MgCl2. Samples were incubated at 37 °C for 4-24 h,
isolated by centrifugation for 10 min at 1200 × g, and washed three times with DI-water.
Alternatively, a pure aqueous solution of 16 mM MgCl2 (Sigma) was used in place of the
buffer solution, which gave particles with the same morphology. PXRD demonstrated that
these samples contained the same magnesium pyrophosphate phase as the RNAi
microsponge samples, namely Mg2P2O7•3.5H2O
Electron Microscopy and Compositional Analysis
Scanning electron microscopy (SEM) images were captured using a JEOL 6700F SEM.
Samples were prepared by drop-casting aqueous suspensions onto silicon wafers and were
imaged without sputter-coating, typically at an accelerating voltage of 2 kV. TEM images
were collected using a JEOL 2010 TEM at an accelerating voltage of 200 kV. EDS maps
were collected on a JEOL 2010F TEM equipped with an analytical scanning imaging device
(ASID) and INCA EDS detector using a 1 nm probe.Chemical compositions were obtained
through wavelength dispersive X-ray spectrometry (WDS) on a JEOL JXA-8200
Superprobe electron probe micro-analyzer (EPMA) at MIT. Data were acquired at an
accelerating voltage of 15 kV using a 4 μm probe diameter. Quantification was carried out
by averaging data collected from 10 locations and using a graphite standard for carbon, an
apatite standard for oxygen and phosphorus, and a diopside-jadeite mineral standard for
magnesium. XPS spectra were collected with a Physical Electronics Versaprobe II X-ray
Photoelectron Spectrometer. Quantification was carried out by averaging data from three
spectra, each collected using a 200 μm spot size.
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Thermogravimetric Analysis and RNA Quantification
Thermogravimetric analysis was performed with a TA Instruments Discovery
Thermogravimetric Analyzer. All samples were run under flowing air and heated at a rate of
10 °C/min. The wt. % RNA in the microsponge samples was calculated using two different
methods. The first method consisted of gravimetrically determining the total mass/volume
RNAi MS concentration by drying a given volume of suspension in the TGA at 90 °C until
the weight became stable. The RNA concentration was measured for the same RNAi MS
sample using a RiboGreen® RNA assay kit (Invitrogen) according to the manufacturer’s
protocol (this assay was done using an EDTA-containing buffer, which we have found
dissolves the particles and releases the RNA). Fluorescence was measured using a Tecan
Infinite M200 Pro 96-well plate reader and concentration was calculated based on an RNA
standard curve. RNA wt. % was then calculated by dividing the RNA concentration by the
gravimetric particle concentration. Measurements were carried out in triplicate for four
independent samples. Alternatively, RNA wt. % was determined by comparing TGA curves
for RNAi microsponge and magnesium pyrophosphate control samples heated to 600 °C
under air. The difference in weight loss for these two samples (more weight loss occurred
for the RNAi MS sample) was assumed to correspond to the RNA content of the RNAi
microsponges; RNA wt. % was therefore calculated by dividing this difference by the final
wt. % of the control sample.
Confocal Microscopy
Cy5-labeled RNAi microsponges were imaged using a Nikon A1R Ultra-Fast Spectral
Scanning Confocal Microscope with a 40X objective at room temperature (Nikon
instruments Inc., Melville, NY). Microsponges were imaged in situ in a CELLview glass
bottom dish (Greiner Bio-One GmbH, Germany). EDTA was added to the microsponge
sample at a concentration of 5 mM followed by temporally resolved imaging of its effect on
the microsponge particles. Imaging conditions remained constant throughout the experiment.
RNase Digestion and Transfection of RNAi Microsponges
RNase If digestions were carried out by adding 100 units of enzyme to a 20 μL volume of 1×
reaction buffer (NEBuffer 3) containing RNAi MS particles with ~1 μg RNA. The reactions
were incubated at 37 °C and terminated by heat deactivation at 70 °C for 10 min. For the
EDTA-treated samples, 4 μL of 50 mM EDTA were added prior to the addition of the
enzyme. For the intact MS-2 samples, EDTA was added after heat deactivation of RNase If
in order to release the RNA prior to transfection. GFP-expressing SKOV3 cells were
transfected with RNAi microsponge samples to investigate target gene silencing after RNase
treatment. For a positive control, an RNAi microsponge sample without RNase treatment
was used and for a negative control, we employed an RNAi microsponge sample not
targeted against GFP (scrambled control). Briefly, EDTA-dissolved RNAi miscrosponge
samples were complexed with the lipofectamine® transfection reagent. The complexes were
prepared according to the manufacturer’s protocol. The cells were first seeded in a 96-well
plate at 30% confluence and after 24 h were treated with the lipoplex samples at 3 pmol
RNA (based on the 21 bp portion) per well. Four days post transfection, the cells were
harvested with trypsin and the cell-associated GFP fluorescence was assessed by flow
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cytometry (excitation 480 nm; emission 530 nm) using a BD LSRFortessa flow cytometer
coupled with a high-throughput system for the 96-well plate format (BD biosciences, San
Jose, CA).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Electron micrographs of MS-2 particles. (a) Low magnification SEM image of MS-2 (scale
bar = 1 μm). (b) MS-2 particle viewed at higher magnification by SEM (scale bar = 100
nm). (c) TEM image of an MS-2 particle (scale bar = 100 nm). (d) TEM image showing the
edge of an MS-2 particle viewed at higher magnification (scale bar = 50 nm).
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Figure 2.
X-ray diffraction and spectroscopic characterization of microsponge particles. (a) PXRD
patterns for MS-2 (blue curve), MS-1 (red curve), magnesium pyrophosphate synthesized
without RNA (green curve), and a simulated diffraction pattern for Mg2P2O7•3.5H2O (black
curve). (b) EDS spectrum obtained from point analysis of MS-2 microsponge particles. (c)
XPS spectrum of an MS-2 sample. (d) Comparison of quantification results obtained for
MS-2 usingWDS and XPS. Error bars represent mean ± SEM.
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Figure 3.
STEM-based EDS mapping of MS-2 particles. (a) STEM image and EDS maps for MS-2
particles taken at low magnification (scale bar = 4 μm). (b) STEM image and EDS maps for
an MS-2 particle at high magnification (scale bar = 600 nm).
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Figure 4.
Confocal fluorescence microscopy of microsponge particles synthesized in the presence of
Cy5-labelled UTP. (a) Low magnification image of MS-2 particles (scale bar = 10 μm). (b)
MS-2 particles viewed at higher magnification (scale bar = 3 μm). (c) MS-2 particles viewed
5 s after the addition of 5 mM EDTA (scale bar = 10 μm). Inset shows capsule structures
after digital magnification. (d) Shows the same field of view as in (c), but 10 s after the
addition of EDTA (scale bar = 10 μm).
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Figure 5.
Characterization of RCT reaction products from DNA-T2 at different time points. (a) Gel
electrophoresis (1.5% agarose) of EDTA-treated particles isolated from an RCT reaction at
different time points. (b) Quantification of RNA (ribogreen assay) produced from RCT
reaction at different time points. PPi concentration (right y-axis) was calculated based on the
measured RNA concentration. Error bars represent mean ± SEM (n = 3). (c) SEM image of
the solid isolated from an RCT reaction after 4 h. (d) SEM image of solid isolated from an
RCT reaction after 6 h. Scale bars are all equal to 1 μm.
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Figure 6.
Electron micrographs of magnesium pyrophosphate control samples formed with and
without RNA. (a-b) SEM and TEM images of spherulitic Mg2PPi-0.5 particles. (c-d) SEM
images of an Mg2PPi-0.5+RNA sample. All scale bars are equal to 1 μm.
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Figure 7.
Gel electrophoresis and transfection of MS-2 treated with RNase If. (a) Agarose gel
electrophoresis of MS-2 sample treated with RNase If for different durations followed by
treatment with EDTA. (b) Agarose gel electrophoresis of MS-2 sample dissolved with
EDTA prior to being treated with RNase If for different durations. (c) Lipofectamine
transfection of GFP-expressing SKOV3 cells using RNA released from GFP-targeted MS-2
particles (or a scrambled control), either before or after treatment with RNase If for 1 h.
Error bars represent mean ± SEM (n = 3).
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Scheme 1.
Components of the RCT reactions. (a) Cartoon illustrating RCT from a circular DNA
template. (b) Sequence and secondary structure of DNA-T1 with the T7 promoter region
highlighted by the curved arrow. (c) Sequence and secondary structure of DNA-T2.
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